TORONTO, July 23 /PRNewswire-FirstCall/ -- Theralase(TM) Technologies Inc. (TSX-V: TLT & OTC BB: TLTFF) announces that it has entered an agreement with University Health Network (UHN) and Ontario Centres of Excellence's (OCE) Centre of Excellence for Photonics, to expand their joint research and development of the Company's patented photodynamic compounds (PDC's), which are activated by its TLC-3000 PDC super-pulsed biofeedback laser technology. Roger White, President and CEO of Theralase Technologies Inc. stated that, "This is a significant milestone for the Company, which further expands research and development of the combined photodynamic compounds and laser technology for the selective destruction of cancers, bacterium, viruses and fat cells. The clinical applications of this technology, if proven successful, could have a significant impact on one of the more devastating diseases of our time." Theralase Technologies Inc. designs, develops and manufactures patented, super-pulsed laser technology used in a wide range of bio-stimulation and bio-destruction clinical applications. The Theralase technology platform targets several diverse healthcare sectors -- firstly, for non-invasive pain management and clinical therapy, in hundreds of neural muscular skeletal conditions, including arthritis -- secondly, to bio-stimulate and accelerate wound care and healing, including; bone fracture regeneration and osteoarthritic conditions -- and thirdly, combining photodynamic compounds with super-pulsed, biofeedback laser technology to attack specifically targeted cancers, bacterium, viruses and fat cells. For a complete profile of Theralase Technologies Inc. and its products visit the corporate website, http://www.theralase.com/ and the regulatory website at http://www.sedar.com/. Ontario Centres of Excellence (OCE) Inc. drives the commercialization of cutting-edge research across key market sectors to build the economy of tomorrow and secure Ontario's global competitiveness. In doing this, OCE fosters the training and development of the next generation of innovators and entrepreneurs and is a key partner with Ontario's industry, universities, colleges, research hospitals, investors and governments. Celebrating 20 years of innovation in 2007, OCE's five Centres work in communications and information technology, earth and environmental technologies, energy, materials and manufacturing and photonics. For more information, please visit OCE's website at http://www.oce-ontario.org/ This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the contents of this release. DATASOURCE: Theralase Technologies Inc. CONTACT: Roger Dumoulin-White, President & CEO, Phone: (905) 947-8455, e-mail:

Copyright